Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide biosynthesis during pregnancy: implications for circulatory changes

M K McLaughlin1, K P Conrad

  • 1Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh, PA, USA.

Clinical and Experimental Pharmacology & Physiology
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular actions of relaxin: nitric oxide and beyond.

British journal of pharmacology·2016
Same author

Altered global gene expression in first trimester placentas of women destined to develop preeclampsia.

Placenta·2008
Same author

Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins.

Placenta·2008
Same author

Mechanisms of renal vasodilation and hyperfiltration during pregnancy: current perspectives and potential implications for preeclampsia.

Endothelium : journal of endothelial cell research·2005
Same author

Expression of von Hippel Lindau (pVHL) protein in placentae from normal pregnant women and women with preeclampsia.

Placenta·2005
Same author

Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae.

Placenta·2004
Same journal

Relationship Between Long-Term Exposure to Airborne Particulate Matter and the Intrinsic Capacity of Middle-Aged and Older Adults in China: A Retrospective Cohort Study Based on CHARLS.

Clinical and experimental pharmacology & physiology·2026
Same journal

Dapagliflozin Improves Mitochondrial Function to Reduce the Risk of Atrial Fibrillation in a High-Glucose Environment by Activating the AMPK/PGC-1α/SIRT3 Signalling Pathway.

Clinical and experimental pharmacology & physiology·2026
Same journal

Hypertension-Mediated Organ Damage: Pathophysiological Mechanisms, Clinical Consequences, and Implications for Early Risk Stratification.

Clinical and experimental pharmacology & physiology·2026
Same journal

Saikosaponin D Alleviates Atherosclerosis by Regulating Autophagy and Senescence of VSMCs via Inhibiting EPHB2.

Clinical and experimental pharmacology & physiology·2026
Same journal

Noninvasively Evaluating the Cerebral Blood Flow Changes After Surgery in Adult Moyamoya Patients Using 3D Pulsed Arterial Spin Labelling MRI.

Clinical and experimental pharmacology & physiology·2026
Same journal

Targeting S100A8/A9 Ameliorates Heart Failure with Preserved Ejection Fraction by Modulating TLR4/NF-κB-Mediated Inflammation.

Clinical and experimental pharmacology & physiology·2026
See all related articles

Nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) increase during pregnancy, but their sources and effects on maternal vasculature require further study, particularly in pregnant women.

Area of Science:

  • Reproductive biology
  • Vascular physiology
  • Biochemistry

Background:

  • Nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) levels rise during pregnancy in rats and humans.
  • The precise origins of increased NO and cGMP during gestation, and their impact on maternal vascular tone, remain unclear.
  • The placenta, specifically the syncytiotrophoblast and fetoplacental endothelium, is a known source of NO production.

Purpose of the Study:

  • To investigate the sources and roles of NO and cGMP during pregnancy.
  • To clarify the contribution of maternal vasculature versus other tissues to NO and cGMP biosynthesis.
  • To explore the potential of NO in regulating maternal vascular smooth muscle behavior and membrane potential.

Main Methods:

  • The abstract does not specify methods, but implies studies in animal models (rats) and humans.

Related Experiment Videos

  • Analysis of plasma and urinary levels of cGMP.
  • Assessment of NO synthase activity in placental tissues.

    • Main Results:

    • NO and cGMP biosynthesis increase from pre-pregnant levels during rat gestation.
    • Elevated plasma and urinary cGMP levels are observed during human pregnancy.
    • The syncytiotrophoblast and fetoplacental endothelium contribute significantly to placental NO production.

    Conclusions:

    • While NO and cGMP increase during pregnancy, their exact contribution to maternal vascular adaptations needs more research.
    • Further studies are required to understand NO's role in reducing maternal vascular tone and reactivity.
    • Translating findings from animal models to pregnant women is essential for comprehensive understanding.